Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated about 15 hours ago
Spyre spies another edge for UC ambitions with midstage win for anti-TL1A antibody
about 15 hours ago
The company's SPY002 prompted a 10.7-point reduction from baseline levels in patients’...
Japan, South Korea challenge the West’s place in research rankings: report
about 16 hours ago
Nature Index’s latest research rankings show that China continues to be the...
Amid US investment tour, J&J makes $1B stop in Florida to upgrade contact lens plant
about 19 hours ago
With Johnson & Johnson gradually fleshing out its $55 billion U.S. investment...
Intellia touts ‘paradigm-shifting’ phase 3 data for one-time HAE treatment
about 20 hours ago
Six weeks after Intellia Therapeutics reported that it met its primary endpoint...
Amgen loses in Harbour antibody patent case, ordered to pay $20M+
about 20 hours ago
A federal jury in Delaware has found that Amgen and its acquired...
Neumora to lay off 35% of staff after navacaprant goes 0 for 3 in late-stage depression studies
about 20 hours ago
Neumora's navacaprant has completed a clean sweep of trial misses in major...
Traws defers midphase flu study after negative regulatory review
about 21 hours ago
U.K. regulators have issued a “negative review” of Traws Pharma’s planned human...
Soligenix axes lymphoma program after phase 3 setback, mulls M&A options
about 22 hours ago
Soligenix has scrapped its cutaneous T-cell lymphoma program in the wake of...
Lilly unveils first clinical data behind $2.3B Ajax deal, showing JAK inhibitor works ‘right out of the gate’
3 days ago
Eli Lilly’s up-to-$2.3 billion acquisition of Ajax Therapeutics is facing its first...
‘I wouldn’t call it a blip’: Biotech IPOs here to stay after another record-breaking listing
4 days ago
Elon Musk's SpaceX may be igniting global headlines with the company's astronomical...
Ipsen R&D chief on pipeline discipline, partnerships and 2026 milestones
4 days ago
Christelle Huguet, Ph.D., Ipsen’s executive vice president and head of R&D, sits...
Guardant Health nabs FDA test approval to find patients for Boehringer’s new cancer drug
4 days ago
Boehringer Ingelheim’s Hernexeos has nabbed a companion diagnostic from Guardant Health after...